Colgate-Palmolive stock (US1941621039): Recent price dip to $86.74

Colgate-Palmolive stock experienced a slight decline on May 11, 2026, closing at $86.74 after opening at $87.39, with a day high of $87.39 and low of $85.97, according to data from the company's investor relations site as of May 11, 2026. This movement reflects ongoing volatility in the consumer staples sector, where the company holds a prominent role for US investors through its NYSE listing under ticker CL.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Colgate-Palmolive: core business model

Colgate-Palmolive operates as a multinational consumer goods company focused primarily on oral care, personal care, home care, and pet nutrition products. The business model centers on research-driven innovation, global brand strength, and extensive distribution networks reaching over 200 countries. Toothpaste remains the cornerstone, with flagship brands like Colgate holding dominant market shares worldwide, including significant penetration in the US market.

The company's structure emphasizes efficiency through a lean supply chain and marketing investments that reinforce brand loyalty. Revenue is generated via a portfolio of everyday essentials, allowing for stable demand even in economic downturns, which appeals to US investors seeking defensive plays in consumer staples.

Main revenue and product drivers for Colgate-Palmolive

Oral care accounts for the majority of revenue, with toothpaste sales leading at over 40% of total sales in recent periods. Key products include Colgate Total and Colgate Optic White, supported by clinical backing for efficacy. Personal care items like Palmolive soaps and home care brands such as Ajax contribute diversely, while Hill's pet nutrition adds a premium growth segment.

In the US, Colgate-Palmolive derives substantial revenue from retail channels including supermarkets and pharmacies, bolstered by e-commerce expansion. The company's ability to premiumize products through whitening and sensitivity formulas drives margins, as noted in historical financial overviews from GuruFocus as of recent updates.

Industry trends and competitive position

The oral care industry faces trends toward natural ingredients and sustainability, where Colgate-Palmolive invests in eco-friendly packaging and fluoride alternatives. Competitors like Procter & Gamble and Unilever challenge market share, but Colgate's R&D spend—around 2-3% of sales—sustains its edge in innovation. In the US, it commands over 30% toothpaste market share per sector data.

Why Colgate-Palmolive matters for US investors

As a NYSE-listed staple with deep US roots, Colgate-Palmolive offers exposure to resilient consumer spending. Its dividend history and market cap of approximately $70.57 billion, as reported by GuruFocus, position it as a core holding in many S&P 500 index funds popular among retail investors.

Conclusion

Colgate-Palmolive continues to demonstrate stability in the consumer goods space, with recent trading reflecting typical sector dynamics. The company's strong brand portfolio and global reach provide a solid foundation, while ongoing innovation supports long-term positioning. US investors track its performance closely given its NYSE presence and dividend appeal.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.